Main Second Level Navigation
Khalid Al-Zahrani
PhD
The Al-Zahrani Lab aims to develop and apply new high throughput in vivo functional genomics tools. We study how large-scale chromosomal alterations drive tumorigenesis and can be leveraged as a therapeutic vulnerability in cancer. While chromosomal instability is a hallmark of cancer, identifying which genes drive tumorigenesis is complicated by the fact that these unstable regions span hundreds-to-thousands of genes which can be lost, gained and/or re-arranged. To overcome this challenge, we perform multiplexed CRISPR screens in mouse models of disease to simultaneously assess the tumorigenic potential of all affected genes to identify cancer-specific drivers and vulnerabilities within the context of a native tumor microenvironment.
Awards
Cancer Research Society Next Generation Scientist